Point-of-Care Troponin Testing in the Emergency Department

Launched by KU LEUVEN · Feb 20, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to quickly test for heart problems in patients who come to the emergency department (ED) with chest pain. The focus is on using a new type of test that can give results in just a few minutes, compared to traditional tests that can take much longer. The goal is to see if this quicker testing method can help patients leave the ED sooner and reduce overcrowding, which can lead to better care for everyone.

Eligible participants for this study are adults aged 18 to 75 who are experiencing chest pain or similar symptoms that might indicate a heart issue. To take part, they must provide written consent and have symptoms that have lasted at least 15 minutes but started within the past 12 hours. If someone joins the study, they will be randomly assigned to either the new quick testing group or the usual testing group. This trial is important because it could improve how quickly and effectively patients are treated in the ED, making the experience better for both patients and healthcare staff.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures - At least 18 years of age at the time of signing the Informed Consent Form (ICF)
• • Age \< 75 years of age
• • Presenting with chest pain or chest pain-equivalent symptom suspect of acute coronary syndrome at the University Hospitals Leuven emergency department; Symptoms must have (had) a minimum duration of 15 minutes, and the current, ongoing episode of symptoms must have started within the past 12 hours.
• Exclusion Criteria:
• • Unable to provide written informed consent
• • Age \<18 years or \>75 years
• • Chest pain or equivalent symptom with a duration shorter than 15 minutes, or an onset of the current, ongoing episode of symptoms more than 12 hours ago
• • Clinically unstable patients or confirmed STEMI patients, requiring immediate treatment
• • Patients with recent chest trauma
• • Patients transferred from another hospital
• • Any disorder, which in the investigator's opinion might jeopardise participant's safety or compliance with the CISP.